Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Management changes at B&L's vision care unit

This article was originally published in Clinica

Executive Summary

Eye health company Bausch & Lomb has promoted Peter Valenti to corporate vice-president and global president of its vision care business. Mr Valenti, who will assume the new role with effect from July 1, succeeds Stuart Heap, who has chosen to step down for "personal reasons". Mr Heap will continue to be an active strategic advisor to the New York, Rochester-based company. Mr Valenti's current position as B&L Vision Care's president for North America will be filled by Steven Robins. Mr Robins was most recently general manager of Johnson & Johnson's Canadian consumer healthcare division, and vice-president of its consumer group.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel